Zobrazeno 1 - 10
of 103
pro vyhledávání: '"Alexander S. Goldfarb-Rumyantzev"'
Publikováno v:
Kidney International Reports, Vol 3, Iss 2, Pp 417-425 (2018)
Because chronic kidney disease (CKD) adversely affects survival, prediction of mortality risk should help to identify individuals requiring therapeutic intervention. The goal of this project was to construct and to validate a risk scoring system and
Externí odkaz:
https://doaj.org/article/74fb41c0acd541f996f814d7ef77bbb0
Publikováno v:
J Hypertens
OBJECTIVES Hypertension is a risk factor for chronic kidney disease (CKD) progression and mortality. However, the optimal blood pressure associated with decreased mortality in each stage of CKD remains uncertain. METHODS In this retrospective cohort
Autor:
Robert S. Brown, Parag Vohra, Shiva Gautam, Ning Dong, Alexander S. Goldfarb-Rumyantzev, Gurprataap S. Sandhu
Publikováno v:
Informatics for healthsocial care. 45(2)
We have previously proposed an approach using information collected from published reports to generate prediction models. The goal of this project was to validate this technique to develop and test various prediction models. A risk indicator (R) is c
Autor:
Alexander S. Goldfarb-Rumyantzev, Robert S. Brown, Bhanu K. Patibandla, Tammy Hod, Akshita Narra
Publikováno v:
Clinical Nephrology. 86:253-261
BACKGROUND In patients with failure of an initial arteriovenous fistula (AVF), a subsequent vascular access is needed before hemodialysis (HD) initiation. METHODS To assess the optimal access strategy after a failed AVF, we linked data from the US Re
Practical Prediction Model for the Risk of 2-Year Mortality of Individuals in the General Population
Publikováno v:
Journal of Investigative Medicine. 64:848-853
This study proposed to validate a prediction model and risk-stratification tool of 2-year mortality rates of individuals in the general population suitable for office practice use. A risk indicator (R) derived from data in the literature was based on
Publikováno v:
Journal of the American Society of Nephrology. 26:448-456
Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis (HD). However, many AVFs fail before starting dialysis. To assess the optimal time for AVF placement in the elderly, we linked data from the US Renal Data System with Medic
Publikováno v:
Kidney International Reports
Kidney International Reports, Vol 3, Iss 2, Pp 417-425 (2018)
Kidney International Reports, Vol 3, Iss 2, Pp 417-425 (2018)
Introduction Because chronic kidney disease (CKD) adversely affects survival, prediction of mortality risk should help to identify individuals requiring therapeutic intervention. The goal of this project was to construct and to validate a risk scorin
Autor:
Bhanu K. Patibandla, Wajih Syed, Yael Vin, Akshita Narra, Varun Chawla, Alexander S. Goldfarb-Rumyantzev, Ranil DeSilva, Tammy Hod
Publikováno v:
Hemodialysis International. 18:686-694
Arteriovenous fistula (AVF) is the preferred vascular access for hemodialysis (HD). Several factors associated with AVF placement have been identified (e.g., age, sex, race, comorbidities). We hypothesized that geographic location of patient residenc
Autor:
Alexander S. Goldfarb-Rumyantzev, Yael Vin, Tammy Hod, Ranil DeSilva, Bhanu K. Patibandla, Robert S. Brown
Publikováno v:
Hemodialysis International. 18:507-515
An arteriovenous fistula (AVF) is the preferential hemodialysis (HD) access. The goal of this study was to identify factors associated with pre-dialysis AVF failure in an elderly HD population. We used United States Renal Data System + Medicare claim
Autor:
Akshita Narra, Alexander S. Goldfarb-Rumyantzev, Yael Vin, Robert S. Brown, Ranil DeSilva, Varun Chawla, Bhanu K. Patibandla
Publikováno v:
Hemodialysis International. 18:118-126
The benefits of an arteriovenous fistula (AVF) as the preferred vascular access for hemodialysis have been clearly demonstrated. However, only about 20% of patients in the United States initiate hemodialysis with an AVF. In this study, we assessed wh